066-33333360

info@madeinlorestan.com

Send us an email.

066-33333360

info@madeinlorestan.com

Send us an email.

Exir Pharmaceutical Complex

Company Profile: Exir Pharmaceutical Plants

Exir Pharmaceutical Plant is situated on a 36-hectare site with a total built-up area of 60,000 square meters in Borujerd, Lorestan Province. As one of the country’s largest industrial units in the field of human pharmaceuticals, the plant leverages advanced production line technology, a comprehensive suite of modern laboratory equipment, and a team of experienced specialists. Currently, the facility manufactures and markets over 160 types of pharmaceutical products in various dosages and forms. The company’s portfolio includes tablets, capsules, ampoules, cartridges, syrups, injectable vials, powders for oral suspension, and soft gelatin capsules (softgels). In addition to these specialized productions, the company focuses on the import and manufacture of exclusive drugs, licensed products, and biotechnological formulations.

The company employs a comprehensive and standardized evaluation system to ensure rigorous quality oversight. Precise and continuous controls are implemented at every stage—from the receipt of raw materials to the final product—within the Quality Control (QC) laboratories and the Quality Assurance (QA) unit, the latter of which serves as a reference laboratory approved by the Ministry of Health.

All processes at Exir Pharmaceutical are designed and executed in strict accordance with GMP (Good Manufacturing Practice) standards and WHO (World Health Organization) guidelines. By integrating cutting-edge technologies and contemporary knowledge, Exir has achieved superior product quality while maintaining competitive pricing for its domestic and international commercial contracts.

Through the export of its products to various countries—including Afghanistan, Ukraine, Yemen, Philippines, Azerbaijan, Tajikistan, Iraq, Syria, Somalia, Sri Lanka, Uganda, Armenia, Venezuela, and Lebanon—the company has been recognized as a “Model Exporter” for six consecutive years, earning the title of a premier exporting company in the country.

Furthermore, the company’s achievements include gaining the trust of prestigious international firms for joint ventures and licensed production. Exir has attained ISO 9001 (Quality Management System), ISO 14001 (Environmental Management System), and OHSAS 18001 (Occupational Health and Safety Management System) certifications. Other notable accolades include being named one of the “Top 100 Brands of Iran” for two consecutive years, winning the Iran Food, Drug, and Health Quality Award for four consecutive years, and receiving the Three-Star Quality Certification.

Additionally, the company has been honored with the Organizational Excellence Award, the Consumer Rights Protection Certificate for three consecutive years, and commendations from the Governor of Borujerd and the Ministry of Cooperatives, Labour, and Social Welfare (as a model “Worker’s Health House”). Success in the formulation and production of new Iranian medications further distinguishes Exir’s portfolio.

Our purposeful performance, driven by a long-term strategic plan, remains a core competitive advantage, guiding us toward balanced development in the coming years to fulfill the expectations of all stakeholders. The track record of Exir Pharmaceutical Plants is further embellished with the Two-Star Organizational Excellence Award and prestigious titles such as “Health-Oriented,” “Green Industry,” and “Top Exporter.”

Competitive advantages Product/products relative to domestic and foreign competitors

Domestic pharmaceutical production, particularly within the Exir Pharmaceutical Complex, offers numerous competitive advantages over both foreign and domestic alternatives, which are of paramount importance to the national healthcare system and the end consumer. 1. Cost Reduction and Economic Accessibility: One of the most prominent advantages of the products manufactured by this complex is their affordability. The elimination of import duties, international shipping costs, lower production overheads, and the removal of import intermediaries ensure that medications reach patients at a significantly lower cost than foreign or other domestic counterparts. Furthermore, the price monitoring by the Food and Drug Administration (FDA) facilitates access to vital medicines for all strata of society. 2. Pharmaceutical Security and Supply Chain Stability: Reliance on domestic production shields the country from currency fluctuations and international sanctions. During global crises or disruptions in the global supply chain, domestic production guarantees the uninterrupted supply of essential medicines (such as serums, injectables, sterile drugs, antibiotics, various tablets, capsules, and oral liquids) to medical centers, thereby preventing drug shortages. In this regard, the Exir Pharmaceutical Complex possesses immense potential among the country's pharmaceutical entities, with diverse production lines including ampoules, liquid and powder vials, non-beta-lactam powder lines, syrups, tablets, capsules, growth hormones, insulin pens, pre-filled syringes, sachets, soft gels, and dental cartridges. 3. Support for Scientific and Industrial Infrastructure: The expansion of the complex's production lines and the implementation of projects based on its defined vision lead to the enhancement of technical knowledge, job creation for specialists in pharmacy, technical engineering, biology, microbiology, and chemistry, and the strengthening of the country's industrial infrastructure. In the long term, this paves the way for the production of more complex and advanced pharmaceuticals, such as biotechnological products. 4. Mitigation of Currency Volatility: Severe fluctuations in exchange rates often lead to unstable pricing or acute shortages of imported medicines. Domestic production, by utilizing local raw materials or optimizing procurement, mitigates these fluctuations. Leveraging the expertise of its specialists, the Exir Pharmaceutical Company strives to localize the production and industrialization of various dosage forms. 5. Adherence to Global Standards: Production within the Exir Pharmaceutical Complex is conducted in accordance with GMP (Good Manufacturing Practice), a global standard. Most of the complex's production lines hold GMP certifications from the Iran Food and Drug Administration as well as from the regulatory bodies of export destination countries. 6. Retention of Technical Know-how: When a domestic company develops a formulation, the technical know-how remains within the country, leading to the creation of optimized versions or higher-quality generic drugs. With a dedicated team of pharmacists, chemists, and engineers working in accredited laboratory environments, this complex has consistently taken effective steps toward achieving its strategic macro-objectives. 7. Engineering and Machinery Innovation: The design and manufacture of specialized pharmaceutical machinery by the company's technical and engineering team—including ampoule particle control systems, ampoule blistering and cartooning machines, effervescent tablet presses, and other equipment—has significantly enhanced the company's bargaining power in both domestic and international markets.

Company registered name :

Exir Pharmaceutical Complex

Company brand :

Exir Pharmaceutical

Name and surname of the CEO :

Dr. Meysam Noormohammadi

Factory address :

Lorestan Province, Borujerd County, km 2 of the Ring Road

Phone :

06642600048

Email :

Info@Exir.Co.ir

Fax :

06642606022

Site :

www.Exir.Co.ir

Office mailing address:

Tehran, km 18 of Tehran-Karaj Special Road, Daroupakhsh St., Gate No. 2 (Residential Gate), Daroupakhsh Plant

Field of activity and production :

Production of pharmaceutical products in the forms of ampoules, vials, pre-filled syringes, tablets, capsules, soft gelatin capsules, syrups, cartridges, and sachets.

Company and product advertising slogans :

"Health is not a dream", "Commitment, Focus, Effort" , "Discipline ,Dedication, Innovation"

Lorestan province, with its pristine nature, fertile soil, and abundant water resources, is one of the most important centers for the production of agricultural, livestock, and aquatic products in Iran. The diversity of products in this province, including wheat, barley, various types of fresh fruits, and cold-water and warm-water fish farming, plays an important role in meeting the country’s food needs. Animal husbandry in Lorestan also plays a significant role in the production of meat and dairy products, and the quality of these products is the result of the use of rich pastures and the efforts of local producers. Made in Lorestan has been created with the aim of introducing and offering these capacities; a secure platform for direct access to high-quality and authentic products of Lorestan.

All material and intellectual property rights of this site belong to the Lorestan Chamber of Commerce.

About the company

Product Image

Competitive advantages Product/products relative to domestic and foreign competitors

Exir Pharmaceutical Complex